New Study: Medicare’s Price Controls Are Fueling America’s Growing Doctor Shortage
The Pacific Research Institute’s Center for Medical Economics and Innovation today released a new issue brief warning that continued federal underpayment of doctors is fueling a looming healthcare crisis by accelerating the nation’s physician shortage and undermining access to care. Written by PRI senior fellow in business and economics and CMEI director Dr. Wayne Winegarden, the brief (titled “It’s Time for Medicare to Stop Shortchanging Physicians”) finds that Medicare reimbursement rates are well below market ...
Trump Puts Drug Pricing Program Fraudsters on Notice
The Trump administration is ramping up its fight against waste, fraud, and abuse in healthcare. And that effort could help make care more affordable for millions of Americans. One of its latest targets is the 340B Drug Pricing Program, a little-known federal initiative that has warped the prescription drug market. Created in 1992, 340B requires drug manufacturers to sell outpatient medicines at steep discounts to certain hospitals and clinics that serve low-income and uninsured patients. ...
Germany Wants Cheaper Drugs—And Americans To Pay The Difference
What does a new healthcare reform effort in Germany have to do with American patients? Quite a lot, actually. The German government is looking to cut healthcare spending by tens of billions of euros. To that end, it is pushing pharmaceutical companies to accept significantly lower prices for new medicines. That may help Germany balance its books. But it comes at a cost to American patients and pharmaceutical innovation. It’s also fundamentally unfair to the ...
Trending Topics
Studies
